US Patent Issued to NEURACLE SCIENCE on Oct. 7 for "Pharmaceutical use of FAM19A5 involved in regulating gliogenesis" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,130, issued on Oct. 7, was assigned to NEURACLE SCIENCE Co. LTD. (Seoul, South Korea).

"Pharmaceutical use of FAM19A5 involved in regulating gliogenesis" was invented by Jae Young Seong (Seoul, South Korea), Jong Ik Hwang (Seoul, South Korea), Woong Sun (Seoul, South Korea), Eun Bee Cho (Seoul, South Korea) and Won-Ki Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the pharmaceutical use of FAM19A5 involved in regulating gliogenesis, and more specifically, to the use of FAM19A5 in the prevention, diagnosis, or treatment of central nervous system injuries, degenerative brain diseases, or central ...